Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

Many regard getting a diagnosis, good or bad, as preferable to living with uncertainty. But if that diagnosis is the wrong ...

Ashleigh Hughes, 38, struggled with back pain for years - but a new "pulsing" implant has had a life-changing impact ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

According to trainer Tony Gentilcore, 'Front squats nudge people into more thoracic extension which is going to be a game ...